Spain’s renowned centre of excellence recognises importance of verifying radiosurgery plans ahead of patient treatment
Proposed combination enhances Pfizer’s position as a leading company in oncology
Open, scalable, end-to-end solution to improve diagnostic quality and efficiency
The Development Center with its state-of-the art laboratories and flexible pilot capacities is set to become Siegfried's global research and development hub for its Drug Products sites, strengthening the global network
Resomer used in commercial 3D-printed implants for both soft and hard tissue applications
The approved product is indicated for the treatment of adult patients with Multiple myeloma, in combination with Dexamethasone
Vigabatrin for Oral Solution USP, 500 mg had annual sales of US $233.7 mn in US
Vigabatrin for Oral Solution USP, 500 mg had annual sales of USD 233.7 mn in the United States
Julian Collins, Jana Windt and Michiel Stork join biopharma company’s leadership team
Receives Subject Expert Committee recommendation to bring new therapies of Pompe, ASMD to India
Subscribe To Our Newsletter & Stay Updated
